All In MedTech

Device Trial Radar · NCT05742347

Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions

Efficacy of a Skin Protectant Textile for the Management of Skin Fold Conditions

Last checked: Nov 20, 2026Latest source record: May 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

47

Actual

Start

Jul 1, 2022

Primary completion

Aug 12, 2024

Study completion Sep 26, 2024

Sponsor

Lead sponsor
Medline IndustriesNot on our public-company list
Sponsor type
Industry
First posted
Feb 24, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy of the DriGo skin protectant textile (SPT) to manage erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor associated with skin folds (henceforth together referred to as "skin fold conditions"). Participants will be patients with skin fold conditions, which will be treated with the SPT. Healthcare providers will apply the SPT to the participants' target areas. A given participant can have up to two target areas enrolled in the study. An independent licensed clinician with experience in identifying and treating skin fold conditions, will use photographs of the skin folds and other skin-on-skin contact areas (henceforth referred to as "target area\[s\]") to assess the status of erythema, maceration, denudation, and satellite lesions in the target areas when the SPT is first applied (Day 0), and on Days 1, 3, and 5, during SPT changes. The Principal Investigator (PI) or qualified designee will take photographs of the target areas and assess moisture and odor in these areas. Participants will provide their impressions of pain, itching and burning in the target area(s) on the same days as the skin fold condition photography. In addition, the study will include feedback from the Health Care Providers (HCPs) about the SPT and overall experience of the participants with the SPT.

Conditions

  • Erythema
  • Maceration
  • Lesion Skin
  • Skin Folds

Interventions

  • DriGo Skin Protectant TextileDevice

    All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ErythemaTime frame: day 0, day 1, day 3
  2. MacerationTime frame: day 0, day 1, day 3.
  3. DenudationTime frame: day 0, day 1, and day 3.

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bryan Medical Center

    Lincoln, Nebraska

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.